Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Oxaliplatin × 90 days × Clear all

Phase

Status

Recruiting 70 Active not recruiting 46 Not yet recruiting 29 Completed 14 Enrolling by invitation 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

pembrolizumab 35 Nivolumab 12 Carboplatin 11 Specimen Handling 10 venetoclax 9 atezolizumab 9 Gemcitabine 9 Biopsy 9 fludarabine 8 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Radiosurgery 7 Pemetrexed 7 Paclitaxel 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Radiotherapy 6 Docetaxel 6 daratumumab 5 Trastuzumab 5 Ipilimumab 5 Interviews as Topic 5 Injections 5 Fulvestrant 5 Drug Therapy 5 Cisplatin 5 tislelizumab 4 ibrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05567835 2026-02-23

TOGAR

Baylor College of Medicine

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡